CureVac takes Moderna to court over mRNA vaccine patents
As Reuters reports, CureVac argues that Moderna copied its mRNA-stabilisation and delivery technologies, which were developed at the…
BioNTech reports promising Phase II data for uterine cancer ADC
Trastuzumab pamirtecan, an investigational HER2‑targeted antibody-drug conjugate developed by BioNTech and DualityBio, has met the primary efficacy endpoint…